Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Dextran 20 Sodium Chloride Injection

Approval Number

国药准字H14020773

Company广东大翔制药有限公司

Registration Date

June 12, 2020

Drug Information

Generic Name

右旋糖酐20氯化钠注射液

Dosage Form

注射剂

Strength

250ml:15g右旋糖酐20与2.25g氯化钠

Drug Type

化学药品

Registration Date

June 12, 2020

Company Information

Applicant Company

Company Name广东大翔制药有限公司

Manufacturing Company

Company Name广东大翔制药有限公司

Company Address

广州市增城区石滩镇元美村（石榴基）

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

右旋糖酐20氯化钠注射液 - NMPA 批准文号 | MedPath